Compare Stocks → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CMMBOTCMKTS:OPTI Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCMMBChemomab Therapeutics$0.78+1.3%$0.67$0.42▼$1.89$8.61M0.34241,012 shs28,961 shsOPTIOptec International$0.00$0.00$0.00▼$0.00$49KN/A45.71 million shs27.15 million shs7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCMMBChemomab Therapeutics+1.17%-1.25%+14.95%+52.75%-51.61%OPTIOptec International+2.44%+40.00%+55.56%+250.00%+950.00%Central Banks Preparing for US Dollar Collapse? (Ad)China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCMMBChemomab Therapeutics3.1897 of 5 stars3.35.00.00.03.31.70.6OPTIOptec InternationalN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCMMBChemomab Therapeutics2.67Moderate Buy$7.00798.59% UpsideOPTIOptec InternationalN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCMMBChemomab TherapeuticsN/AN/AN/AN/A$1.54 per shareN/AOPTIOptec InternationalN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCMMBChemomab Therapeutics-$24.22M-$2.12N/AN/AN/AN/A-114.00%-88.53%5/9/2024 (Estimated)OPTIOptec InternationalN/AN/A0.00∞N/AN/AN/AN/AN/ALatest HVO, OPTI, 4BB, IXI, and CMMB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/7/202412/31/2023CMMBChemomab Therapeutics-$0.40-$0.26+$0.14-$0.26N/AN/A DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCMMBChemomab TherapeuticsN/AN/AN/AN/AN/AOPTIOptec InternationalN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCMMBChemomab TherapeuticsN/A4.324.16OPTIOptec InternationalN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipCMMBChemomab Therapeutics46.05%OPTIOptec InternationalN/AInsider OwnershipCompanyInsider OwnershipCMMBChemomab Therapeutics11.91%OPTIOptec International50.34%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCMMBChemomab Therapeutics2011.05 million9.73 millionNot OptionableOPTIOptec International111.65 millionN/ANot OptionableHVO, OPTI, 4BB, IXI, and CMMB HeadlinesSourceHeadlineAdvancements in Optical Fiber Manufacturing Aboard the ISSmsn.com - March 25 at 5:50 PMOPTEC INTERNATIONAL'S RECENT ACQUISITION OF ARTIFICIAL INTELLIGENCE DRIVEN MEDTECH COMPANY WITH SALES OF $59 MILLION...br.advfn.com - March 6 at 4:41 PMRB Capital Partners, Inc. Officially Moves Forward with Appointment of a Receiver for Optec International, Inc.globenewswire.com - February 27 at 8:30 AMoptical mousehackaday.com - February 20 at 5:59 PMDive Deeper Into Trends, Challenges, And Opportunities Of The Global Optical Cable Crossing Connection Cabinet Marketopprairie.com - February 20 at 7:32 AMoptical illusionhackaday.com - February 16 at 2:59 PMChanging Dynamics Of The Global Handheld Optical Coherence Tomography (OCT) Device Market In The Coming Yearsopprairie.com - February 15 at 3:36 PMSTL fosters cultural and community connections with its Optical solutions in BAPS temple, Abu Dhabidevdiscourse.com - February 15 at 10:35 AMChanging Dynamics Of The Global Optical Loop Market In The Coming Yearsopprairie.com - February 14 at 8:33 AMRB Capital Partners, Inc. Announces Shareholder Update for Optec International, Inc.markets.businessinsider.com - February 12 at 3:27 PMOptical Limiter Market Dynamics: A Strategic Market Overviewopprairie.com - February 5 at 8:10 PMExploring The Applications Of Optical Phase Demodulator Market In The Coming Yearsopprairie.com - February 5 at 8:00 AMOptimist Club celebrates International Optimist Day with preschool field triprichlandsource.com - February 4 at 10:19 AMChanging Dynamics Of The Global Optical pH Sensors Market In The Coming Yearsopprairie.com - February 2 at 10:46 AMOptical industry goes from labor division to integration; AOET launches transformation plandigitimes.com - January 5 at 6:25 AMSPIE, the International Society for Optics and Photonics, Announces Its 2024 Fellowsjoplinglobe.com - January 3 at 3:57 PMOpti-Harvest Lifts Expected IPO to 2.65M Unitsmarketwatch.com - December 29 at 6:27 PMZenni Optical Promo Codeswashingtonpost.com - December 19 at 8:35 AMOpticooler from DoKaSch Temperature Solutions certified by Air Canada Cargoaircargoweek.com - December 13 at 9:54 AMOptical I/O Takes Center Stage at SC23insidehpc.com - November 7 at 7:37 AMOptec International Inc OPTImorningstar.com - November 5 at 8:05 PMExplosive Growth Forecasted for Global Passive Optical Network Equipment Market, Fueled by Surging Demand for High-Speed Broadband - ResearchAndMarkets.combusinesswire.com - November 2 at 6:15 PMZenni Optical Military Discountmilitary.com - October 30 at 11:20 PMOptical Mouse Based Scannerhackaday.com - October 28 at 11:35 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Stocks With Unusual Call Option ActivityMarch 26, 2024 1:10 PMView 3 Stocks With Unusual Call Option Activity3 Stocks About to Boom on Unusual Call Option VolumeMarch 18, 2024 8:46 AMView 3 Stocks About to Boom on Unusual Call Option VolumeBest Bear Market Funds: Top 3 Investment Options to ConsiderMarch 27, 2024 10:58 AMView Best Bear Market Funds: Top 3 Investment Options to ConsiderDelta Airline’s Put Option Activity Isn’t Bad NewsMarch 28, 2024 8:55 AMView Delta Airline’s Put Option Activity Isn’t Bad NewsPANW Profits from Pelosi: Former House Speaker’s Recent TradesFebruary 29, 2024 7:00 AMView PANW Profits from Pelosi: Former House Speaker’s Recent TradesAll Headlines Company DescriptionsChemomab TherapeuticsNASDAQ:CMMBChemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody had completed Phase 2a clinical trials that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.Optec InternationalOTCMKTS:OPTIOptec International, Inc. engages in selling and marketing optimized fuel maximizer units in North America and internationally. It markets optimized fuel maximizer for passenger vehicles, intermediate/medium duty trucks, off-road equipment, generator systems, heavy duty diesel on-road vehicles, and transportation refrigeration units. The company was formerly known as Green Meadow Products, Inc. and changed its name to Optec International, Inc. in August 2017. Optec International, Inc. was founded in 2012 and is based in Carlsbad, California. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.